Literature DB >> 11506394

Aerobic conditioning in patients with mitochondrial myopathies: physiological, biochemical, and genetic effects.

T Taivassalo1, E A Shoubridge, J Chen, N G Kennaway, S DiMauro, D L Arnold, R G Haller.   

Abstract

Aerobic training has been shown to increase work and oxidative capacity in patients with mitochondrial myopathies, but the mechanisms underlying improvement are not known. We evaluated physiological (cycle exercise, 31P-MRS), biochemical (enzyme levels), and genetic (proportion of mutant/wild-type genomes) responses to 14 weeks of bicycle exercise training in 10 patients with heteroplasmic mitochondrial DNA (mtDNA) mutations. Training increased peak work and oxidative capacities (20-30%), systemic arteriovenous O2 difference (20%), and 31P-MRS indices of metabolic recovery (35%), consistent with enhanced muscle oxidative phosphorylation. Mitochondrial volume in vastus lateralis biopsies increased significantly (50%) and increases in deficient respiratory chain enzymes were found in patients with Complex I (36%) and Complex IV (25%) defects, whereas decreases occurred in 2 patients with Complex III defects (approximately 20%). These results suggest that the cellular basis of improved oxygen utilization is related to training-induced mitochondrial proliferation likely resulting in increased levels of functional, wild-type mtDNA. However, genetic analysis indicated the proportion of wild-type mtDNA was unchanged (3/9) or fell (6/9), suggesting a trend toward preferential proliferation of mutant genomes. The long-term implications of training-induced increases in mutant relative to wild-type mtDNA, despite positive physiological and biochemical findings, need to be assessed before aerobic training can be proposed as a general treatment option.

Entities:  

Mesh:

Year:  2001        PMID: 11506394     DOI: 10.1002/ana.1050

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  46 in total

Review 1.  Regulation of mitochondrial biogenesis in muscle by endurance exercise.

Authors:  Isabella Irrcher; Peter J Adhihetty; Anna-Maria Joseph; Vladimir Ljubicic; David A Hood
Journal:  Sports Med       Date:  2003       Impact factor: 11.136

Review 2.  Mitochondria.

Authors:  P F Chinnery; E A Schon
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-09       Impact factor: 10.154

Review 3.  Altering the balance between healthy and mutated mitochondrial DNA.

Authors:  Paul M Smith; Robert N Lightowlers
Journal:  J Inherit Metab Dis       Date:  2010-05-27       Impact factor: 4.982

Review 4.  Mitochondrial DNA mutations in human disease.

Authors:  Robert W Taylor; Doug M Turnbull
Journal:  Nat Rev Genet       Date:  2005-05       Impact factor: 53.242

5.  Exertional dyspnea in mitochondrial myopathy: clinical features and physiological mechanisms.

Authors:  Katja Heinicke; Tanja Taivassalo; Phil Wyrick; Helen Wood; Tony G Babb; Ronald G Haller
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-08-03       Impact factor: 3.619

Review 6.  Barth syndrome: cardiolipin, cellular pathophysiology, management, and novel therapeutic targets.

Authors:  Hana M Zegallai; Grant M Hatch
Journal:  Mol Cell Biochem       Date:  2021-01-07       Impact factor: 3.396

7.  Novel mutation of ND4 gene identified by targeted next-generation sequencing in patient with Leigh syndrome.

Authors:  Bing Xu; Xiyuan Li; Miaomiao Du; Chao Zhou; Hezhi Fang; Jianxin Lyu; Yanling Yang
Journal:  J Hum Genet       Date:  2016-10-20       Impact factor: 3.172

8.  Dynamic phosphocreatine imaging with unlocalized pH assessment of the human lower leg muscle following exercise at 3T.

Authors:  Oleksandr Khegai; Guillaume Madelin; Ryan Brown; Prodromos Parasoglou
Journal:  Magn Reson Med       Date:  2017-05-30       Impact factor: 4.668

9.  Mitochondrial dysfunctions in myalgic encephalomyelitis/chronic fatigue syndrome explained by activated immuno-inflammatory, oxidative and nitrosative stress pathways.

Authors:  Gerwyn Morris; Michael Maes
Journal:  Metab Brain Dis       Date:  2013-09-10       Impact factor: 3.584

10.  OPA1 mutations cause cytochrome c oxidase deficiency due to loss of wild-type mtDNA molecules.

Authors:  Patrick Yu-Wai-Man; Kamil S Sitarz; David C Samuels; Philip G Griffiths; Amy K Reeve; Laurence A Bindoff; Rita Horvath; Patrick F Chinnery
Journal:  Hum Mol Genet       Date:  2010-05-18       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.